James Hamilton
Corporate Officer/Principal chez ARROWHEAD PHARMACEUTICALS, INC.
Fortune : 6 M $ au 31/03/2024
Profil
James C.
Hamilton is the founder of NanoValent Pharmaceuticals, Inc. (founded in 2005).
He is currently the Chief Discovery & Translational Medicine at Arrowhead Pharmaceuticals, Inc. He was formerly the Chief Executive Officer at Calando Pharmaceuticals, Inc. Dr. Hamilton received his undergraduate degree from Miami University and his MBA and doctorate degrees from The Ohio State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 204 851 ( 0,17% ) | 6 M $ | 31/03/2024 |
Postes actifs de James Hamilton
| Sociétés | Poste | Début |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| NanoValent Pharmaceuticals, Inc. | Founder | 23/02/2010 |
Anciens postes connus de James Hamilton
| Sociétés | Poste | Fin |
|---|---|---|
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | President | - |
Formation de James Hamilton
| Miami University | Undergraduate Degree |
| The Ohio State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Health Technology |
| NanoValent Pharmaceuticals, Inc. |
